Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target

被引：114

作者：

Krystof, Vladimir ^{[1
,2
]}

Baumli, Sonja ^{[3
]}

Fuerst, Robert ^{[4
]}

机构：

[1] Palacky Univ, Lab Growth Regulators, Fac Sci, Olomouc 78371, Czech Republic

[2] Inst Expt Bot ASCR, Olomouc 78371, Czech Republic

[3] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

[4] Univ Munich, Dept Pharm, Ctr Drug Res Pharmaceut Biol, D-81377 Munich, Germany

来源：

CURRENT PHARMACEUTICAL DESIGN | 2012年 / 18卷 / 20期

基金：

英国医学研究理事会;

关键词：

Cancer; inflammation; kinase; P-TEFb; inhibitor; therapeutics; angiogenesis; FLAVOPIRIDOL INDUCES APOPTOSIS; GROWTH-FACTOR EXPRESSION; MULTIPLE-MYELOMA CELLS; P-TEFB; TRANSCRIPTION ELONGATION; KAPPA-B; DOWN-REGULATION; CDK9/CYCLIN T1; SELICICLIB CYC202; CRYSTAL-STRUCTURE;

D O I：

10.2174/138161212800672750

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Deregulation of cyclin-dependent kinases (CDKs) has been associated with many cancer types and has evoked an interest in chemical inhibitors with possible therapeutic benefit. While most known inhibitors display broad selectivity towards multiple CDKs, recent work highlights CDK9 as the critical target responsible for the anticancer activity of clinically evaluated drugs. In this review, we discuss recent findings provided by structural biologists that may allow further development of highly specific inhibitors of CDK9 towards applications in cancer therapy. We also highlight the role of CDK9 in inflammatory processes and diseases.

引用

页码：2883 / 2890

页数：8

共 50 条

[21] Serum cyclin-dependent kinase 9 is a potential biomarker of atherosclerotic inflammation [J].

Han, Yeming ;

Zhao, Shanshan ;

Gong, Yaoqin ;

Hou, Guihua ;

Li, Xi ;

Li, Li .

ONCOTARGET, 2016, 7 (02) :1854-1862

[22] Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation [J].

Olson, Calla M. ;

Jiang, Baishan ;

Erb, Michael A. ;

Liang, Yanke ;

Doctor, Zainab M. ;

Zhang, Zinan ;

Zhang, Tinghu ;

Kwiatkowski, Nicholas ;

Boukhali, Myriam ;

Green, Jennifer L. ;

Haas, Wilhelm ;

Nomanbhoy, Tyzoon ;

Fischer, Eric S. ;

Young, Richard A. ;

Bradner, James E. ;

Winter, Georg E. ;

Gray, Nathanael S. .

NATURE CHEMICAL BIOLOGY, 2018, 14 (02) :163-+

[23] Cyclin-dependent kinase (CDK) 9 and 4/6 inhibitors in acute myeloid leukemia (AML): a promising therapeutic approach [J].

Lee, Daniel J. ;

Zeidner, Joshua F. .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (11) :989-1001

[24] The anti-human cytomegalovirus drug tricin inhibits cyclin-dependent kinase 9 [J].

Sadanari, Hidetaka ;

Fujimoto, Kazuhiro J. ;

Sugihara, Yuto ;

Ishida, Tomoki ;

Takemoto, Masaya ;

Daikoku, Tohru ;

Murayama, Tsugiya .

FEBS OPEN BIO, 2018, 8 (04) :646-654

[25] Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation [J].

Mbonye, Uri ;

Wang, Benlian ;

Gokulrangan, Giridharan ;

Shi, Wuxian ;

Yang, Sichun ;

Karn, Jonathan .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (26) :10009-10025

[26] Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma [J].

Narita, Tomoko ;

Ishida, Takashi ;

Ito, Asahi ;

Masaki, Ayako ;

Kinoshita, Shiori ;

Suzuki, Susumu ;

Takino, Hisashi ;

Yoshida, Takashi ;

Ri, Masaki ;

Kusumoto, Shigeru ;

Komatsu, Hirokazu ;

Imada, Kazunori ;

Tanaka, Yuetsu ;

Takaori-Kondo, Akifumi ;

Inagaki, Hiroshi ;

Scholz, Arne ;

Lienau, Philip ;

Kuroda, Taruho ;

Ueda, Ryuzo ;

Iida, Shinsuke .

BLOOD, 2017, 130 (09) :1114-1124

[27] Cyclin-Dependent Kinase 9 Inhibition Suppresses Necroptosis and Pyroptosis in the Progress of Endotoxemia [J].

Li, Jiao ;

Mao, Huimin ;

Pan, Yue ;

Li, Houxuan ;

Lei, Lang .

INFLAMMATION, 2020, 43 (06) :2061-2074

[28] Targeting cyclin-dependent kinase 9 in cancer therapy [J].

Yi-li Shen ;

Yan-mao Wang ;

Ya-xin Zhang ;

Shen-jie Ma ;

Le-he Yang ;

Cheng-guang Zhao ;

Xiao-ying Huang .

Acta Pharmacologica Sinica, 2022, 43 :1633-1645

[29] Cyclin-dependent kinase 9 may as a novel target in downregulating the atherosclerosis inflammation (Review) [J].

Han, Yeming ;

Zhan, Yang ;

Hou, Guihua ;

Li, Li .

BIOMEDICAL REPORTS, 2014, 2 (06) :775-779

[30] Cyclin-dependent kinase 9-cyclin K functions in the replication stress response [J].

Yu, David S. ;

Zhao, Runxiang ;

Hsu, Emory L. ;

Cayer, Jennifer ;

Ye, Fei ;

Guo, Yan ;

Shyr, Yu ;

Cortez, David .

EMBO REPORTS, 2010, 11 (11) :876-882

← 1 2 3 4 5 →